Negotiating Drug Prices in the US—Lessons From Europe
- 2 December 2022
- journal article
- editorial
- Published by American Medical Association (AMA) in JAMA Health Forum
- Vol. 3 (12) , e224801
Abstract
This Viewpoint describes European drug price negotiation practices and compares them with practices in the US.Keywords
This publication has 4 references indexed in Scilit:
- New Reforms to Prescription Drug Pricing in the USJAMA, 2022
- Analysis of Launch and Postapproval Cancer Drug Pricing, Clinical Benefit, and Policy Implications in the US and EuropeJAMA Oncology, 2021
- The use of ‘added benefit’ to determine the price of new anti-cancer drugs in France, 2004–2017European Journal of Cancer, 2021
- The Impact Of Price Regulation On The Availability Of New Drugs In GermanyHealth Affairs, 2019